Skip to main content

Table 6 Summary of anchor-based and distribution-based estimates for the MCID of RS-SCs

From: Minimum clinical important difference for resilience scale specific to cancer: a prospective analysis

Scale

Approach

Anchor/method

MCID estimate

Improvement

Deterioration

RS-SC-10

Distribution

S.E.M

3.51a

− 3.51a

Distribution

0.5SD

4.39a

− 4.39a

Linear regression

QoL GHS

3.62

− 2.59

Linear regression

CD-RISC-10

3.29

− 2.26

Linear regression

HADS-A

3.05

− 2.61

Linear regression

HADS-D

3.42

− 2.48

ROC

QoL GHS

2.00

− 1.50

ROC

CD-RISC-10

2.00

− 1.50

ROC

HADS-A

2.00

− 1.50

ROC

HADS-D

2.00

− 1.50

RS-SC-25

Distribution

S.E.M

9.18 a

− 9.18 a

Distribution

0.5SD

10.66 a

− 10.66 a

Linear regression

QoL GHS

9.31

− 6.81

Linear regression

CD-RISC-10

8.56

− 6.19

Linear regression

HADS-A

8.78

− 7.05

Linear regression

HADS-D

8.97

− 6.79

ROC

QoL-total

5.50

− 4.50

ROC

CD-RISC-10

5.50

− 4.50

ROC

HADS-A

5.50

− 4.50

ROC

HADS-D

5.50

− 4.50

  1. a Mean